Viewing nowEgliptin 100 mg Tablet (Sitagliptin Hydrochloride Monohydrate)
Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 202101300 · Approved 2021.02.16 · Insurance code 658204600
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used alongside diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can also be administered alone, and if blood sugar control is inadequate when starting diabetes treatment, it can be combined with metformin. Additionally, when blood sugar control is difficult with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added for combination therapy. Furthermore, for patients whose blood sugar control is insufficient, even after combining multiple medications, additional combination therapy including this medication is recommended. It is used in various scenarios to improve patients' blood sugar management.
This medicine is administered at a dose of 100 mg once daily when used as monotherapy or in combination therapy. The maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, reducing the dose of the sulfonylurea or insulin may be considered to decrease the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting treatment with this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication can cause rare but serious allergic reactions. Symptoms such as anaphylaxis, angioedema, and severe skin disorders may occur, and if such symptoms are suspected, it is important to stop taking the medication immediately and consult a doctor. During the administration of this medication, pancreatitis, which is inflammation of the pancreas, may occur, so if symptoms such as abdominal pain, vomiting, or nausea appear, the healthcare provider should be notified immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and patients who have had severe allergic reactions to this medication or its ingredients should also avoid it. Patients with impaired kidney function may have delayed excretion of this medication, so dosage adjustments may be necessary, and regular checks of kidney function are important. This medication has the potential to cause hypoglycemia when used alone or in combination with other diabetes medications. Extra caution is required, especially when used with insulin or sulfonylureas, as the risk of hypoglycemia increases, and dosage adjustments for other medications may be needed if necessary. If severe joint pain or skin blistering occurs during administration, notify the doctor immediately and discontinue use. This medication is not recommended for women who are pregnant or breastfeeding, and the safety and efficacy in children and adolescents under 18 years of age have not been established. Elderly patients may have decreased kidney function, so kidney function tests should be conducted before and after taking this medication, and dosage adjustments may be needed. In cases of overdose, general emergency measures should be taken, and some can be removed through dialysis, so proper medical intervention is required. This medication has relatively few drug interactions, but efficacy or side effects may vary when used in combination with certain drugs, so all medications taken should be reported to the doctor or pharmacist.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents degradation.
Bright brown, round, and convex film-coated tablets on both sides
PTP - 28 tablets/PTP [(14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.